ctrl K

Price Alert

Tourmaline Bio Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

22.05

-0.32 (-1.43%)

At close: Aug 20, 2025, 9:47 AM

Tourmaline Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.51M	140.73M	8.26M	18.61M
Short-Term Investments	227.8M	62.23M	n/a	225.36M
Long-Term Investments	36.63M	n/a	216K	n/a
Other Long-Term Assets	3.26M	974K	n/a	104K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	10.54M	5.92M	n/a	-243.82M
Total Current Assets	268.84M	208.87M	8.31M	150K
Property-Plant & Equipment	267K	447K	570K	4.8M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	40.16M	1.42M	786K	4.91M
Total Assets	309M	210.29M	9.1M	150K
Account Payables	3.58M	1.07M	401K	194K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	227K	221K	162K	150K
Other Current Liabilities	3.6M	1.77M	-162K	n/a
Total Current Liabilities	8.91M	5M	1.36M	376K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	23K	57K	27.13M	626K
Total Long-Term Liabilities	40K	251K	27.47M	626K
Total Liabilities	8.95M	5.25M	28.83M	376K
Total Debt	244K	415K	504K	150K
Common Stock	3K	2K	4K	4K
Retained Earnings	-135.26M	-62.05M	-19.93M	-90.85M
Comprehensive Income	296K	67K	-721K	-78K
Shareholders Equity	300.05M	205.04M	-19.73M	242.81M
Total Investments	264.43M	62.23M	216K	225.36M